General Discussion
In reply to the discussion: THIS !!! [View all]We have seen this happen with so many companies. Dexcom, which was first started with the idea of helping type 1 D, at least by some, said they wanted to help people and bring their prices down. Instead they never brought them down, did not improve the product that much, got fda approval for something they should not have, and turned themselves into a billion $ company by the above and focusing more on type 2 who are much more numerous.
All people with d should have access to low cost cgm if they want/need it. Now there is some competition but the competition is still not as good for those who need real continuous cgm. Another thing they did was to keep their tech under raps for a long time, I can't find info on it now but they may still be doing this.
In addition, relevant to this post, when they expanded, they outsourced their customer service overseas to save money- firing many employees here. The employees here were much better and were largely people who had diabetes etc.
Edit history
Recommendations
3 members have recommended this reply (displayed in chronological order):